Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health
Abstract
:1. Introduction
2. Civilization Diseases
3. Diabetes
3.1. Lifestyle Factors and T2D
3.2. Genetic and Epigenetic Factors and T2D
4. Polyphenols and Cyanidin-3-O-glucoside
Role of Cyanidin-3-O-glucoside (C3G) in Diabetes
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
References
- Tucker, K.L.; Smith, C.E.; Lai, C.Q.; Ordovas, J.M. Quantifying diet for nutrigenomic studies. Ann. Rev. Nutr. 2013, 33, 349–371. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carrera-Bastos, P.; Fontes-Villalba, M.; HO’Keefe, J.; Lindeberg, S.; Cordain, L. The western diet and lifestyle and diseases of civilization. Clin. Res. Cardio. 2011, 2, 15–35. [Google Scholar] [CrossRef] [Green Version]
- Temelkova-Kurktschiev, T.; Stefanov, T. Lifestyle and genetics in obesity and type 2 diabetes. Exp. Clin. Endocrinol. Diabetes. 2012, 120, 1–6. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ali, O. Genetics of type 2 diabetes. World J. Diabetes 2013, 4, 114. [Google Scholar] [CrossRef]
- Bahadoran, Z.; Mirmiran, P.; Azizi, F. Dietary polyphenols as potential nutraceuticals in management of diabetes: A review. J. Diabetes Metab. Disord. 2013, 12, 43. [Google Scholar] [CrossRef] [Green Version]
- Tan, J.; Li, Y.; Hou, D.-X.; Wu, S. The Effects and Mechanisms of Cyanidin-3-Glucoside and Its Phenolic Metabolites in Maintaining Intestinal Integrity. Antioxidants 2019, 8, 479. [Google Scholar] [CrossRef] [Green Version]
- Scalbert, A.; Manach, C.; Morand, C.; Rémésy, C.; Jiménez, L. Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 2005, 45, 287–306. [Google Scholar] [CrossRef] [PubMed]
- Bhullar, K.S.; Rupasinghe, H.P. Polyphenols: Multipotent therapeutic agents in neurodegenerative diseases. Oxidative Med. Cell. Longev. 2013, 2013, 891748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dryden, G.W.; Song, M.; McClain, C. Polyphenols and gastrointestinal diseases. Curr. Opin. Gastroenterol. 2006, 22, 165–170. [Google Scholar] [CrossRef] [Green Version]
- Gasmi, A.; Mujawdiya, P.K.; Noor, S.; Lysiuk, R.; Darmohray, R.; Piscopo, S.; Lenchyk, L.; Antonyak, H.; Dehtiarova, K.; Shanaida, M.; et al. Polyphenols in Metabolic Diseases. Molecules 2022, 27, 6280. [Google Scholar] [CrossRef]
- Tseng, P.S.; Ande, C.; Moremen, K.W.; Crich, D. Influence of side chain conformation on the activity of glycosidase inhibitors. Angew. Chem. Int. 2023, 135, e202217809. [Google Scholar] [CrossRef]
- Rajasekaran, P.; Ande, C.; Vankar, Y.D. Synthesis of (5, 6 & 6, 6)-oxa-oxa annulated sugars as glycosidase inhibitors from 2-formyl galactal using iodocyclization as a key step. Arkivoc 2022, 2022, 5–23. [Google Scholar] [CrossRef]
- Chennaiah, A.; Bhowmick, S.; Vankar, Y.D. Conversion of glycals into vicinal-1,2-diazides and 1, 2-(or 2,1)-azidoacetates using hypervalent iodine reagents and Me 3 SiN 3. Application in the synthesis of N-glycopeptides, pseudo-trisaccharides and an iminosugar. RSC Adv. 2017, 7, 41755–41762. [Google Scholar] [CrossRef] [Green Version]
- Available online: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases (accessed on 27 April 2023).
- Çetin, M.; Bakirtaş, I. Does Urbanization Induce the Health Expenditures? A Dynamic Macro-Panel Analysis for Developing Countries. Dumlupınar Üniversitesi Sos. Bilimler Derg. 2019, 61, 208–222. [Google Scholar]
- Goryakin, Y.; Rocco, L.; Suhrcke, M. The contribution of urbanization to non-communicable diseases: Evidence from 173 countries from 1980 to 2008. Econ. Hum. Biol. 2017, 26, 151–163. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, W.; Zheng, R.; Zhang, S.; Zeng, H.; Zuo, T.; Xia, C.; Yang, Z.; He, J. Cancer incidence and mortality in China in 2013: An analysis based on urbanization level. Chin. J. Cancer Res. 2017, 29, 1–10. [Google Scholar] [CrossRef] [Green Version]
- Voss, J.D.; Masuoka, P.; Webber, B.J.; Scher, A.I.; Atkinson, R.L. Association of elevation, urbanization and ambient temperature with obesity prevalence in the United States. Int. J. Obes. 2013, 37, 1407–1412. [Google Scholar] [CrossRef] [Green Version]
- Akpan, E.E.; Ekpenyong, C.E. Urbanization Drift and Obesity Epidemic in Sub-Saharan Africa: A Review of the Situation in Nigeria. Eur. J. Sustain. Dev. 2013, 2, 141. [Google Scholar] [CrossRef]
- Hales, C.M.; Fryar, C.D.; Carroll, M.D.; Freedman, D.S.; Aoki, Y.; Ogden, C.L. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA 2018, 319, 2419–2429. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ogden, C.L.; Fryar, C.D.; Hales, C.M.; Carroll, M.D.; Aoki, Y.; Freedman, D.S. Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013–2016. JAMA 2018, 319, 2410–2418. [Google Scholar] [CrossRef] [Green Version]
- Hossain, M.; Khan, J.R.; Adhikary, A.C.; Anwar AH, M.; Raheem, E.; Siddiqee, M.H.; Hossain, M.S. Association between childhood overweight/obesity and urbanization in developing countries: Evidence from Bangladesh. J. Public Health 2022, 30, 2819–2828. [Google Scholar] [CrossRef]
- Available online: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed on 5 January 2023).
- Internation Diabetes Federation. Diabetes Atlas, 10th ed.; IDF: Brussels, Belgium, 2021; Available online: https://www.diabetesatlas.org (accessed on 7 January 2023).
- DeFronzo, R.A. Pathogenesis of type 2 diabetes mellitus. Med. Clin. N. Am. 2004, 88, 787–835. [Google Scholar] [CrossRef] [PubMed]
- Bunney, P.E.; Zink, A.N.; Holm, A.A.; Billington, C.J.; Kotz, C.M. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol. Behav. 2017, 176, 139–148. [Google Scholar] [CrossRef]
- Fu, Z.; Gilbert, E.R.; Liu, D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr. Diabetes Rev. 2013, 9, 25–53. [Google Scholar] [CrossRef]
- Galicia-Garcia, U.; Benito-Vicente, A.; Jebari, S.; Larrea-Sebal, A.; Siddiqi, H.; Uribe, K.B.; Ostolaza, H.; Martín, C. Pathophysiology of Type 2 Diabetes Mellitus. Int. J. Mol. Sci. 2020, 21, 6275. [Google Scholar] [CrossRef] [PubMed]
- Ozougwu, J.C.; Obimba, K.C.; Belonwu, C.D.; Unakalamba, C.B. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J. Physiol. Pathophysiol. 2013, 4, 46–57. [Google Scholar] [CrossRef] [Green Version]
- Zheng, Y.; Ley, S.H.; Hu, F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018, 14, 88–98. [Google Scholar] [CrossRef] [PubMed]
- Lima, J.E.; Moreira, N.C.; Sakamoto-Hojo, E.T. Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia. Mutat. Res. Toxicol. Environ. Mutagen. 2022, 874, 503437. [Google Scholar] [CrossRef]
- Ralph, A.D. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus. Diabetes 2009, 58, 773–795. [Google Scholar] [CrossRef] [Green Version]
- Devaraj, S.; Wang-Polagruto, J.; Polagruto, J.; Keen, C.L.; Jialal, I. High-fat, energy-dense, fast-food–style breakfast results in an increase in oxidative stress in metabolic syndrome. Metabolism 2008, 57, 867–870. [Google Scholar] [CrossRef] [Green Version]
- Dali-Youcef, N.; Mecili, M.; Ricci, R.; Andres, E. Metabolic inflammation: Connecting obesity and insulin resistance. Ann. Med. 2013, 45, 242–253. [Google Scholar] [CrossRef]
- Forouhi, N.G.; Misra, A.; Mohan, V.; Taylor, R.; Yancy, W. Dietary and nutritional approaches for prevention and management of type 2 diabetes. BMJ 2018, 361, k2234. [Google Scholar] [CrossRef] [Green Version]
- Szczepańska, E.; Białek-Dratwa, A.; Janota, B.; Kowalski, O. Dietary Therapy in Prevention of Cardiovascular Disease (CVD)—Tradition or Modernity? A Review of the Latest Approaches to Nutrition in CVD. Nutrients 2022, 14, 2649. [Google Scholar] [CrossRef]
- Rahati, S.; Shahraki, M.; Arjomand, G.; Shahraki, T. Food pattern, lifestyle and diabetes mellitus. Int. J. High Risk Behav. Addict. 2014, 10, e8725. [Google Scholar] [CrossRef] [Green Version]
- Kopp, W. How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases. Diabetes Metab. Syndr. Obes. Targets Ther. 2019, 12, 2221–2236. [Google Scholar] [CrossRef] [Green Version]
- Schulze, M.B.; Hoffmann, K.; Manson, J.E.; Willett, W.C.; Meigs, J.B.; Weikert, C.; Heidemann, C.; Colditz, G.A.; Hu, F.B. Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am. J. Clin. 2005, 82, 675–684. [Google Scholar] [CrossRef]
- Yeung, A.W.K.; Tzvetkov, N.T.; Durazzo, A.; Lucarini, M.; Souto, E.B.; Santini, A.; Gan, R.-Y.; Jozwik, A.; Grzybek, W.; Horbańczuk, J.O.; et al. Natural products in diabetes research: Quantitative literature analysis. Nat. Prod. Res. 2021, 35, 5813–5827. [Google Scholar] [CrossRef]
- Evans, J.L.; Goldfine, I.D.; Maddux, B.A.; Grodsky, G.M. Are oxidative stress− activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 2003, 52, 1–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Scivittaro, V.; Ganz, M.B.; Weiss, M.F. AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells. Am. J. Physiol. 2000, 278, F676–F683. [Google Scholar] [CrossRef] [Green Version]
- Association, A.D. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care 2019, 42, S29–S33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Frank, B.H. Globalization of Diabetes: The role of diet, lifestyle, and genes. Diabetes Care 2011, 34, 1249–1257. [Google Scholar] [CrossRef] [Green Version]
- Schnurr, T.M.; Jakupović, H.; Carrasquilla, G.D.; Ängquist, L.; Grarup, N.; Sørensen, T.I.A.; Tjønneland, A.; Overvad, K.; Pedersen, O.; Hansen, T.; et al. Obesity, unfavourable lifestyle and genetic risk of type 2 diabetes: A case-cohort study. Diabetologia 2020, 63, 1324–1332. [Google Scholar] [CrossRef]
- Groop, L.; Forsblom, C.; Lehtovirta, M.; Tuomi, T.; Karanko, S.; Nissén, M.; Ehrnström, B.O.; Forsén, B.; Isomaa, B.; Snickars, B.; et al. Metabolic consequences of a family history of NIDDM (the Botnia study): Evidence for sex-specific parental effects. Diabetes 1996, 45, 1585–1593. [Google Scholar] [CrossRef] [PubMed]
- Morris, A.P.; Voight, B.F.; Teslovich, T.M.; Ferreira, T.; Segrè, A.V.; Steinthorsdottir, V.; Strawbridge, R.J.; Khan, H.; Grallert, H.; Mahajan, A.; et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat. Genet. 2012, 44, 981–990. [Google Scholar] [CrossRef] [Green Version]
- Lyssenko, V.; Nagorny, C.L.; Erdos, M.R.; Wierup, N.; Jonsson, A.; Spégel, P.; Bugliani, M.; Saxena, R.; Fex, M.; Pulizzi, N.; et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nature Genet. 2009, 41, 82–88. [Google Scholar] [CrossRef] [PubMed]
- Wu, Y.; Li, H.; Loos, R.J.; Yu, Z.; Ye, X.; Chen, L.; Pan, A.; Hu, F.B.; Lin, X. Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population. Diabetes 2008, 57, 2834–2842. [Google Scholar] [CrossRef] [Green Version]
- Ng, M.C.; Park, K.S.; Oh, B.; Tam, C.H.; Cho, Y.M.; Shin, H.D.; Lam, V.K.; Ma, R.C.; So, W.Y.; Cho, Y.S.; et al. Implication of Genetic Variants Near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in Type 2 Diabetes and Obesity in 6,719 Asians. Diabetes 2008, 57, 2226–2233. [Google Scholar] [CrossRef] [Green Version]
- Yasuda, K.; Miyake, K.; Horikawa, Y.; Hara, K.; Osawa, H.; Furuta, H.; Hirota, Y.; Mori, H.; Jonsson, A.; Sato, Y.; et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet. 2008, 40, 1092–1097. [Google Scholar] [CrossRef] [PubMed]
- DeFronzo, R.A.; Ferrannini, E.; Groop, L.; Henry, R.R.; Herman, W.H.; Holst, J.J.; Hu, F.B.; Kahn, C.R.; Raz, I.; Shulman, G.I.; et al. Type 2 diabetes mellitus. Nat. Rev. Dis. Prim. 2015, 1, 15019. [Google Scholar] [CrossRef] [PubMed]
- Daily, J.W.; Liu, M.; Park, S. High genetic risk scores of SLIT3, PLEKHA5 and PPP2R2C variants increased insulin resistance and interacted with coffee and caffeine consumption in middle-aged adults. Nutr. Metab. Cardiovasc. Dis. 2019, 29, 79–89. [Google Scholar] [CrossRef]
- Jin, T.; Youn, J.; Kim, A.N.; Kang, M.; Kim, K.; Sung, J.; Lee, J.E. Interactions of habitual coffee consumption by genetic polymorphisms with the risk of prediabetes and Type 2 diabetes combined. Nutrients 2020, 12, 2228. [Google Scholar] [CrossRef]
- Go, M.J.; Hwang, J.-Y.; Kim, Y.J.; Oh, J.H.; Kim, Y.-J.; Kwak, S.H.; Park, K.S.; Lee, J.; Kim, B.-J.; Han, B.-G.; et al. New susceptibility loci in MYL2, C12orf51 and OAS1 associated with 1-h plasma glucose as predisposing risk factors for type 2 diabetes in the Korean population. J. Hum. Genet. 2013, 58, 362–365. [Google Scholar] [CrossRef]
- Karachanak-Yankova, S.; Dimova, R.; Nikolova, D.; Nesheva, D.; Koprinarova, M.; Maslyankov, S.; Tafradjiska, R.; Gateva, P.; Velizarova, M.; Hammoudeh, Z.; et al. Epigenetic alterations in patients with type 2 diabetes mellitus. Balk. J. Med. Genet. 2015, 18, 15–24. [Google Scholar] [CrossRef] [Green Version]
- Ding, G.-L.; Wang, F.-F.; Shu, J.; Tian, S.; Jiang, Y.; Zhang, D.; Wang, N.; Luo, Q.; Zhang, Y.; Jin, F.; et al. Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine Hyperglycemia. Diabetes 2012, 61, 1133–1142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Walker, K.Z.; O’dea, K.; Gomez, M.; Girgis, S.; Colagiuri, R. Diet and exercise in the prevention of diabetes. J. Hum. Nutr. Diet. 2010, 23, 344–352. [Google Scholar] [CrossRef]
- Pabich, M.; Materska, M. Biological effect of soy isoflavones in the prevention of civilization diseases. Nutrients 2019, 11, 1660. [Google Scholar] [CrossRef] [Green Version]
- Yeung, A.W.K.; Choudhary, N.; Tewari, D.; El-Demerdash, A.; Horbanczuk, O.K.; Das, N.; Pirgozliev, V.; Lucarini, M.; Durazzo, A.; Souto, E.B.; et al. Quercetin: Total-scale literature landscape analysis of a valuable nutraceutical with numerous potential applications in the promotion of human and animal health a review. Anim. Sci. Pap. Rep. 2021, 39, 199–212. [Google Scholar]
- Maleki Dana, P.; Sadoughi, F.; Asemi, Z.; Yousefi, B. The role of polyphenols in overcoming cancer drug resistance: A comprehensive review. CMBL 2022, 27, 1. [Google Scholar] [CrossRef] [PubMed]
- Yeung, A.W.K.; Choudhary, N.; Tewari, D.; El-Demerdash, A.; Tomczyk, M.; Das, N.; Pirgozliev, V.; Lucarini, M.; Durazzo, A.; Souto, E.B.; et al. Lycopene: Total-scale literature landscape analysis of a valuable nutraceutical with numerous potential applications in the promotion of human and animal health. Anim. Sci. Pap. Rep. 2022, 40, 119–134. [Google Scholar]
- Karak, P. Biological activities of flavonoids: An overview. Int. J. Pharm. Sci. Res. 2019, 10, 1567–1574. [Google Scholar] [CrossRef]
- Pecyna, P.; Wargula, J.; Murias, M.; Kucinska, M. More than resveratrol: New insights into stilbene-based compounds. Biomolecules 2020, 10, 1111. [Google Scholar] [CrossRef]
- Brooks, M.S.L.; Celli, G.B. (Eds.) Anthocyanins from Natural Sources: Exploiting Targeted Delivery for Improved Health; Royal Society of Chemistry: London, UK, 2019; p. 315. [Google Scholar] [CrossRef]
- Yeung, A.W.K.; Tzvetkov, N.T.; El-Demerdash, A.; Horbanczuk, O.K.; Das, N.; Pirgozliev, V.; Lucarini, M.; Durazzo, A.; Souto, E.B.; Santini, A.; et al. Apple polyphenols in human and animal health. Anim. Sci. Pap. Rep. 2021, 39, 105–118. [Google Scholar]
- Spínola, V.; Pinto, J.; Llorent-Martínez, E.J.; Tomás, H.; Castilho, P.C. Evaluation of Rubus grandifolius L. (wild blackberries) activities targeting management of type-2 diabetes and obesity using in vitro models. Food Chem. Toxicol. 2019, 123, 443–452. [Google Scholar] [CrossRef]
- Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr. Res. 2017, 61, 1361779. [Google Scholar] [CrossRef] [Green Version]
- Czank, C.; Cassidy, A.; Zhang, Q.; Morrison, D.J.; Preston, T.; Kroon, P.A.; Botting, N.P.; Kay, C.D. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: A 13C-tracer study. Am. Clin. Nutr. 2013, 97, 995–1003. [Google Scholar] [CrossRef] [Green Version]
- Olivas-Aguirre, F.J.; Rodrigo-García, J.; Martínez-Ruiz ND, R.; Cárdenas-Robles, A.I.; Mendoza-Díaz, S.O.; Álvarez-Parrilla, E.; González-Aguilar, G.A.; De la Rosa, D.A.; Ramos-Jiménez, A.; Wall-Medrano, A. Cyanidin-3-O-glucoside: Physical-chemistry, foodomics and health effects. Molecules 2016, 21, 1264. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rahman, S.; Mathew, S.; Nair, P.; Ramadan, W.S.; Vazhappilly, C.G. Health benefits of cyanidin-3-glucoside as a potent modulator of Nrf2-mediated oxidative stress. Inflammopharmacology 2021, 29, 907–923. [Google Scholar] [CrossRef]
- Evaluation of Certain Food Additives: Eighty-Seventh Report of the Joint FAO/WHO Expert Committee on Food Additives; (WHO Technical Report Series; No. 1020). Licence: CC BY-NC-SA 3.0 IGO; World Health Organization and Food and Agriculture Organization of the United Nations: Geneva, Switzerland, 2019.
- Davinelli, S.; Bertoglio, J.C.; Zarrelli, A.; Pina, R.; Scapagnini, G. A randomized clinical trial evaluating the efficacy of an anthocyanin–maqui berry extract (Delphinol®) on oxidative stress biomarkers. J. Am. Coll. Nutr. 2015, 34 (Suppl. S1), 28–33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, X.; Yang, B.; Tan, J.; Jiang, J.; Li, D. Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2016, 70, 1360–1367. [Google Scholar] [CrossRef] [PubMed]
- Akkarachiyasit, S.; Charoenlertkul, P.; Yibchok-Anun, S.; Adisakwattana, S. Inhibitory activities of cyanidin and its glycosides and synergistic effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Int. J. Mol. Sci. 2010, 11, 3387–3396. [Google Scholar] [CrossRef] [Green Version]
- Choi, K.; Choi, S.-I.; Park, M.H.; Han, J.-S. Cyanidin-3-O-glucoside Ameliorates Postprandial Hyperglycemia in Diabetic Mice. J. Life Sci. 2017, 27, 32–37. [Google Scholar] [CrossRef]
- Ştefănuţ, M.N.; Căta, A.; Pop, R.; Tănasie, C.; Boc, D.; Ienaşcu, I.; Ordodi, V. Anti-hyperglycemic effect of bilberry, blackberry and mulberry ultrasonic extracts on diabetic rats. Plant Foods Hum Nutr. 2013, 68, 378–384. [Google Scholar] [CrossRef]
- Sun, C.D.; Zhang, B.; Zhang, J.K.; Xu, C.J.; Wu, Y.L.; Li, X.; Chen, K.S. Cyanidin-3-glucoside-rich extract from Chinese bayberry fruit protects pancreatic β cells and ameliorates hyperglycemia in streptozotocin-induced diabetic mice. J. Med. Food. 2012, 15, 288–298. [Google Scholar] [CrossRef] [Green Version]
- Chen, Y.; Li, X.; Su, L.; Hu, Q.; Li, W.; He, J.; Zhao, L. Cyanidin-3-O-glucoside ameliorates palmitic-acid-induced pancreatic beta cell dysfunction by modulating chop-mediated endoplasmic reticulum stress pathways. Nutrients 2022, 14, 1835. [Google Scholar] [CrossRef]
- Liu, M.; Weiss, M.A.; Arunagiri, A.; Yong, J.; Rege, N.; Sun, J.; Haataja, L.; Kaufman, R.J.; Arvan, P. Biosynthesis, structure, and folding of the insulin precursor protein. Diabetes Obes. Metab. 2018, 20, 28–50. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, S.; Kaufman, R.J. The impact of the unfolded protein response on human disease. J. Cell Biol. 2012, 197, 857–867. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guo, H.; Ling, W. The update of anthocyanins on obesity and type 2 diabetes: Experimental evidence and clinical perspectives. Rev. Endocr. Metab. Disord. 2015, 16, 1–13. [Google Scholar] [CrossRef]
- Ruderman, N.B.; Carling, D.; Prentki, M.; Cacicedo, J.M. AMPK, insulin resistance, and the metabolic syndrome. J. Clin Investig. 2013, 123, 2764–2772. [Google Scholar] [CrossRef] [Green Version]
- Guo, H.; Guo, J.; Jiang, X.; Li, Z.; Ling, W. Cyanidin-3-O-β-glucoside, a typical anthocyanin, exhibits antilipolytic effects in 3T3-L1 adipocytes during hyperglycemia: Involvement of FoxO1-mediated transcription of adipose triglyceride lipase. Food Chem. Toxicol. 2012, 50, 3040–3047. [Google Scholar] [CrossRef]
- Scazzocchio, B.; Varì, R.; Filesi, C.; D’Archivio, M.; Santangelo, C.; Giovannini, C.; Galvano, F.; Masella, R. Cyanidin-3-O-β-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARγ activity in human omental adipocytes. Diabetes 2011, 60, 2234–2244. [Google Scholar] [CrossRef] [Green Version]
- Hiukka, A.; Maranghi, M.; Matikainen, N.; Taskinen, M.R. PPARα: An emerging therapeutic target in diabetic microvascular damage. Nat. Rev. Endocrinol. 2010, 6, 454–463. [Google Scholar] [CrossRef]
- Ahmadian, M.; Suh, J.M.; Hah, N.; Liddle, C.; Atkins, A.R.; Downes, M.; Evans, R.M. PPARγ signaling and metabolism: The good, the bad and the future. Nat. Med. 2013, 19, 557–566. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, L.; Waltenberger, B.; Pferschy-Wenzig, E.M.; Blunder, M.; Liu, X.; Malainer, C.; Blazevic, T.; Schwaiger, S.; Rollinger, J.M.; Heiss, E.H.; et al. Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): A review. Biochem. Pharmacol. 2014, 92, 73–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Moller, D.E.; Berger, J.P. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int. J. Obes. 2003, 27, S17–S21. [Google Scholar] [CrossRef] [Green Version]
- Jia, Y.; Wu, C.; Kim, Y.-S.; Yang, S.O.; Kim, Y.; Kim, J.-S.; Jeong, M.-Y.; Lee, J.H.; Kim, B.; Lee, S.; et al. A dietary anthocyanin cyanidin-3-O-glucoside binds to PPARs to regulate glucose metabolism and insulin sensitivity in mice. Commun. Biol. 2020, 3, 514. [Google Scholar] [CrossRef]
- Solverson, P. Anthocyanin bioactivity in obesity and diabetes: The essential role of glucose transporters in the gut and periphery. Cells 2020, 9, 2515. [Google Scholar] [CrossRef]
- Sasaki, R.; Nishimura, N.; Hoshino, H.; Isa, Y.; Kadowaki, M.; Ichi, T.; Tanaka, A.; Nishiumi, S.; Fukuda, I.; Ashida, H.; et al. Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice. Biochem. Pharmacol. 2007, 74, 1619–1627. [Google Scholar] [CrossRef] [PubMed]
- Yang, Q.; Graham, T.E.; Mody, N.; Preitner, F.; Peroni, O.D.; Zabolotny, J.M.; Kotani, K.; Quadro, L.; Kahn, B.B. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005, 436, 356–362. [Google Scholar] [CrossRef]
- Kahn, B.B. Facilitative glucose transporters: Regulatory mechanisms and dysregulation in diabetes. J. Clin. Investig. 1992, 89, 1367–1374. [Google Scholar] [CrossRef] [Green Version]
- Matsukawa, T.; Inaguma, T.; Han, J.; Villareal, M.O.; Isoda, H. Cyanidin-3-glucoside derived from black soybeans ameliorate type 2 diabetes through the induction of differentiation of preadipocytes into smaller and insulin-sensitive adipocytes. J. Nutr. Biochem. 2015, 26, 860–867. [Google Scholar] [CrossRef] [PubMed]
- Nigro, E.; Scudiero, O.; Monaco, M.L.; Palmieri, A.; Mazzarella, G.; Costagliola, C.; Bianco, A.; Daniele, A. New insight into adiponectin role in obesity and obesity-related diseases. Biomed Res. Int. 2014, 2014, 658913. [Google Scholar] [CrossRef] [PubMed]
- Yogosawa, S.; Mizutani, S.; Ogawa, Y.; Izumi, T. Activin Receptor-Like Kinase 7 Suppresses Lipolysis to Accumulate Fat in Obesity Through Downregulation of Peroxisome Proliferator–Activated Receptor γ and C/EBPα. Diabetes 2013, 62, 115–123. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bartel, I.; Koszarska, M.; Strzałkowska, N.; Tzvetkov, N.T.; Wang, D.; Horbańczuk, J.O.; Wierzbicka, A.; Atanasov, A.G.; Jóźwik, A. Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health. Int. J. Mol. Sci. 2023, 24, 9765. https://doi.org/10.3390/ijms24119765
Bartel I, Koszarska M, Strzałkowska N, Tzvetkov NT, Wang D, Horbańczuk JO, Wierzbicka A, Atanasov AG, Jóźwik A. Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health. International Journal of Molecular Sciences. 2023; 24(11):9765. https://doi.org/10.3390/ijms24119765
Chicago/Turabian StyleBartel, Iga, Magdalena Koszarska, Nina Strzałkowska, Nikolay T. Tzvetkov, Dongdong Wang, Jarosław O. Horbańczuk, Agnieszka Wierzbicka, Atanas G. Atanasov, and Artur Jóźwik. 2023. "Cyanidin-3-O-glucoside as a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health" International Journal of Molecular Sciences 24, no. 11: 9765. https://doi.org/10.3390/ijms24119765